drugset
drugset / Trial / NCT07618299

Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

NCT07618299 ↗

Phase 4 Not yet recruiting 24 enrolled Meitheal Pharmaceuticals, Inc.
NaSingle-groupOpen-labelOther

Summary

Evaluation of the Excretion of Fosfomycin into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

Timeline

Start
2026-07
Primary completion
2027-08
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosfomycin Small molecule 6 g Intravenous

Indications

No indication recorded.